Paper Details

  1. Home
  2. Paper Details

Erlotinib-Induced Cardiomyopathy in a Patient with Metastatic Non-Small Cell Lung Cancer.

Author: IedaMasaki, NagashioKenji, SatoKimi, TajiriKazuko

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This case report describes a patient who developed cardiomyopathy during erlotinib treatment for non-small cell lung cancer (NSCLC), highlighting the potential cardiotoxic effects of erlotinib.
Paper Details　
Original Abstract of the Article :
Erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor, is a targeted drug used for the treatment of non-small cell lung cancer (NSCLC). Erlotinib is considered relatively safe and generally well-tolerated, with rarely reported cardiac side effects. Herein, we report a case of card...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1536/ihj.21-130

データ提供：米国国立医学図書館（NLM）

The Unexpected Desert Oasis: Erlotinib and Cardiomyopathy

Erlotinib, a targeted therapy for non-small cell lung cancer (NSCLC), is generally considered safe and well-tolerated. However, this research highlights a rare but potential side effect of erlotinib: cardiomyopathy. They report a case of a 70-year-old woman who developed cardiomyopathy after starting erlotinib treatment. It's like discovering a hidden oasis in a seemingly barren desert, revealing a previously unknown aspect of the drug's effects.

The Importance of Cardiac Monitoring

This case underscores the importance of careful cardiac monitoring in patients receiving erlotinib treatment. While rare, the potential for cardiomyopathy highlights the need for vigilance and early detection of any cardiac abnormalities. This study emphasizes the importance of individualized treatment plans, considering the patient's overall health and potential risks.

Balancing Benefits and Risks of Erlotinib

This case highlights the delicate balance between the potential benefits and risks of erlotinib treatment. While the drug can be effective in treating NSCLC, healthcare providers must carefully weigh the potential for cardiac complications. It's like navigating a desert with a valuable treasure but also facing potential hazards along the way.

Dr.Camel's Conclusion

This case serves as a reminder that even well-established medications can have unexpected side effects. It emphasizes the importance of ongoing research and careful monitoring to ensure the safety and effectiveness of cancer treatments.

Date :
  1. Date Completed 2021-10-11
  2. Date Revised 2021-10-11
Further Info :

Pubmed ID

34497169

DOI: Digital Object Identifier

10.1536/ihj.21-130

Related Literature

Article Analysis
・Side Effects of erlotinib
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.